MPO-ANCA seropositive participants had a higher probability of being in kidney failure (KDIGO stage 5) at diagnosis than PR3-ANCA seropositive participants (0.36 (95% CI 0.23 to 0.52) vs 0.09 (95% CI 0.05 to 0.15)). This evidence concerns the gene MPO and kidney failure.